Siloam Vision, Inc.

Siloam Vision, Inc. is a corporate entity based in Lake Oswego, Oregon, specializing in advanced medical imaging technologies with a focus on artificial intelligence (AI) applications in ophthalmology. The company develops sophisticated retinal imaging systems and AI-driven diagnostic tools, primarily targeting pediatric and military healthcare applications. Registered in SAM.gov since February 2022, Siloam Vision is a for-profit organization that has successfully secured federal contracts and grants in the medical technology sector.

The company has been awarded a significant federal contract from the Air Force Research Laboratory (AFRL) under the Small Business Innovation Research (SBIR) Program Phase II. This firm fixed-price purchase order, valued at $1,249,151.00, is specifically focused on developing an advanced ultra-widefield retinal imaging system with AI analytics designed to detect debilitating ocular pathologies in military personnel, particularly pilots. The contract, set aside for small businesses, has a completion date of February 22, 2027, and represents Siloam Vision's commitment to innovative medical technology solutions for military healthcare needs.

Siloam Vision has received two notable federal grants from the National Eye Institute, both centered on revolutionary pediatric retinal imaging technologies addressing Retinopathy of Prematurity (ROP). The first grant, awarded on September 30, 2024, aims to develop ultrawide field non-mydriatic portable pediatric retinal imaging systems using infrared laser-based cameras with ultra-widefield imaging capabilities. The second grant, awarded on September 30, 2023, focuses on validating an AI-based Software as a Medical Device (SaMD) for ROP diagnosis. Both grants support the development of advanced imaging technologies that can potentially prevent childhood blindness by providing accurate, quick, and less invasive diagnostic tools, with completion dates in 2025 and innovative approaches to leveraging AI in medical imaging.